Share Price | Sensei Biotherapeutics, Inc. Stock Analysis & Recommendation

Q: How big is Sensei Biotherapeutics, Inc.?

Market Cap: As of Jun 18, Sensei Biotherapeutics, Inc. has a market capitalization of 8.26 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, Sensei Biotherapeutics, Inc. reported net sales of 0.00 million and a net profit of -29.02 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 38.39 million and total assets of 46.21 million.

Q: What does Sensei Biotherapeutics, Inc. do?

Overview:Sensei Biotherapeutics, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.Financial Snapshot:Most recent Net Profit: -7 Million (Quarterly Results - Mar 2025) Market cap: USD 8.26 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.01 Return on Equity: -87.78% Price to Book: 0.26 Contact Details:Details: No Company Details Available Registrar Address: Not available.

Q: Is Sensei Biotherapeutics, Inc. technically bullish or bearish?

As of 4 September 2025, the technical trend for Sensei Biotherapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are bullish, while the monthly MACD and KST are mildly bullish, indicating some positive momentum. However, the daily moving averages are mildly bearish, suggesting short-term weakness. The Bollinger Bands show a bullish stance weekly but are mildly bearish monthly, adding to the mixed signals. The stock has underperformed the S&P 500 over the 1-week, YTD, and 1-year periods, with returns of -0.53%, -5.12%, and -4.26% respectively, compared to the S&P 500's positive returns. Overall, the current stance is mildly bullish, but caution is warranted due to mixed indicators and recent underperformance.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

63.63 k

Shareholding (Jun 2025)

FII

0.47%

Held by 6 FIIs

DII

96.15%

Held by 3 DIIs

Promoter

0.00%

How big is Sensei Biotherapeutics, Inc.?

22-Jun-2025

As of Jun 18, Sensei Biotherapeutics, Inc. has a market capitalization of 8.26 million, with net sales of 0.00 million and a net profit of -29.02 million over the latest four quarters. The company reported shareholder's funds of 38.39 million and total assets of 46.21 million as of Dec 24.

View full answer

What does Sensei Biotherapeutics, Inc. do?

22-Jun-2025

Sensei Biotherapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $7 million and a market cap of $8.26 million. Key metrics include a negative P/E ratio, a debt-to-equity ratio of -1.01, and a return on equity of -87.78%.

View full answer

Is Sensei Biotherapeutics, Inc. technically bullish or bearish?

20-Sep-2025

As of September 4, 2025, Sensei Biotherapeutics, Inc. shows a mildly bullish trend with mixed indicators, including bullish weekly MACD and KST but mildly bearish daily moving averages, and has underperformed the S&P 500 over various periods, suggesting caution despite some positive momentum.

View full answer

Compare Sensei Biotherapeutics, Inc. with Similar Stocks

Forte Biosciences, Inc.Pluri, Inc.Rain Oncology, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 12 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.98

Return on Equity

-94.72%

Price to Book

0.43

Revenue and Profits:

Net Sales:

(Quarterly Results - Mar 2025)

Net Profit:

-7 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

1953.99%

6 Months

1761.7%

1 Year

1206.36%

2 Years

548.15%

3 Years

326.83%

4 Years

-26.22%

5 Years

0.0%

Sensei Biotherapeutics, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-8.38%

EBIT to Interest (avg)

-38.61

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.01

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.30%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.27

EV to EBIT

0.78

EV to EBITDA

0.79

EV to Capital Employed

23.50

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

3020.70%

ROE (Latest)

-87.78%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Sideways

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 4 Schemes (3.38%)

Foreign Institutions

Held by 6 Foreign Institutions (0.47%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Mar 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2025 is 13.75% vs 21.57% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.20",
          "val2": "-8.60",
          "chgp": "16.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.90",
          "val2": "-8.00",
          "chgp": "13.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.44% vs 29.84% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-31.10",
          "val2": "-36.50",
          "chgp": "14.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-30.20",
          "val2": "-34.10",
          "chgp": "11.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY

Mar'25

Mar'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-7.20

-8.60

16.28%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-6.90

-8.00

13.75%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

Consolidated Net Profit

YoY Growth in quarter ended Mar 2025 is 13.75% vs 21.57% in Mar 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-31.10

-36.50

14.79%

Interest

0.10

Exceptional Items

-1.00

0.00

Consolidate Net Profit

-30.20

-34.10

11.44%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 11.44% vs 29.84% in Dec 2023

All Annual Results

Company CV

About Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Sensei Biotherapeutics, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Sensei Biotherapeutics, Inc.?

Watch in Real-Time

What does Sensei Biotherapeutics, Inc. do?

Is Sensei Biotherapeutics, Inc. technically bullish or bearish?

Compare Sensei Biotherapeutics, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Sensei Biotherapeutics, Inc.

Company Coordinates